BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38356202)

  • 1. Controlled WASp activity regulates the proliferative response for Treg cell differentiation in the thymus.
    Vasconcelos-Fontes L; Vieira RC; He M; Ferreira-Reis R; Jurberg AD; Arêas Mendes-da-Cruz D; Andersson J; Cotta-de-Almeida V; Westerberg LS
    Eur J Immunol; 2024 May; 54(5):e2350450. PubMed ID: 38356202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WASP regulates suppressor activity of human and murine CD4(+)CD25(+)FOXP3(+) natural regulatory T cells.
    Marangoni F; Trifari S; Scaramuzza S; Panaroni C; Martino S; Notarangelo LD; Baz Z; Metin A; Cattaneo F; Villa A; Aiuti A; Battaglia M; Roncarolo MG; Dupré L
    J Exp Med; 2007 Feb; 204(2):369-80. PubMed ID: 17296785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Wiskott-Aldrich syndrome protein is required for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells.
    Maillard MH; Cotta-de-Almeida V; Takeshima F; Nguyen DD; Michetti P; Nagler C; Bhan AK; Snapper SB
    J Exp Med; 2007 Feb; 204(2):381-91. PubMed ID: 17296786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired in vitro regulatory T cell function associated with Wiskott-Aldrich syndrome.
    Adriani M; Aoki J; Horai R; Thornton AM; Konno A; Kirby M; Anderson SM; Siegel RM; Candotti F; Schwartzberg PL
    Clin Immunol; 2007 Jul; 124(1):41-8. PubMed ID: 17512803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis.
    Humblet-Baron S; Sather B; Anover S; Becker-Herman S; Kasprowicz DJ; Khim S; Nguyen T; Hudkins-Loya K; Alpers CE; Ziegler SF; Ochs H; Torgerson T; Campbell DJ; Rawlings DJ
    J Clin Invest; 2007 Feb; 117(2):407-18. PubMed ID: 17218989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes.
    Zhang J; Shehabeldin A; da Cruz LA; Butler J; Somani AK; McGavin M; Kozieradzki I; dos Santos AO; Nagy A; Grinstein S; Penninger JM; Siminovitch KA
    J Exp Med; 1999 Nov; 190(9):1329-42. PubMed ID: 10544204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
    Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
    J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Wiskott-Aldrich Syndrome Protein Deficiency on IL-10-Producing Regulatory B Cells in Humans and Mice.
    Du HQ; Zhang X; An YF; Ding Y; Zhao XD
    Scand J Immunol; 2015 Jun; 81(6):483-93. PubMed ID: 25728049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activating WASP mutations associated with X-linked neutropenia result in enhanced actin polymerization, altered cytoskeletal responses, and genomic instability in lymphocytes.
    Westerberg LS; Meelu P; Baptista M; Eston MA; Adamovich DA; Cotta-de-Almeida V; Seed B; Rosen MK; Vandenberghe P; Thrasher AJ; Klein C; Alt FW; Snapper SB
    J Exp Med; 2010 Jun; 207(6):1145-52. PubMed ID: 20513746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations of the Wiskott-Aldrich Syndrome Protein affect protein expression and dictate the clinical phenotypes.
    Ochs HD
    Immunol Res; 2009; 44(1-3):84-8. PubMed ID: 19082760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The open conformation of WASP regulates its nuclear localization and gene transcription in myeloid cells.
    Looi CY; Sasahara Y; Watanabe Y; Satoh M; Hakozaki I; Uchiyama M; Wong WF; Du W; Uchiyama T; Kumaki S; Tsuchiya S; Kure S
    Int Immunol; 2014 Jun; 26(6):341-52. PubMed ID: 24402308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A function for IL-7R for CD4+CD25+Foxp3+ T regulatory cells.
    Bayer AL; Lee JY; de la Barrera A; Surh CD; Malek TR
    J Immunol; 2008 Jul; 181(1):225-34. PubMed ID: 18566388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Wiskott-Aldrich syndrome: The actin cytoskeleton and immune cell function.
    Blundell MP; Worth A; Bouma G; Thrasher AJ
    Dis Markers; 2010; 29(3-4):157-75. PubMed ID: 21178275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 2 modulates thymic-derived regulatory T cell epigenetic landscape.
    Chorro L; Suzuki M; Chin SS; Williams TM; Snapp EL; Odagiu L; Labrecque N; Lauvau G
    Nat Commun; 2018 Dec; 9(1):5368. PubMed ID: 30560927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive activation of WASp in X-linked neutropenia renders neutrophils hyperactive.
    Keszei M; Record J; Kritikou JS; Wurzer H; Geyer C; Thiemann M; Drescher P; Brauner H; Köcher L; James J; He M; Baptista MA; Dahlberg CI; Biswas A; Lane DP; Song W; Pütsep K; Vandenberghe P; Snapper SB; Westerberg LS
    J Clin Invest; 2018 Aug; 128(9):4115-4131. PubMed ID: 30124469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid hormone differentially modulates the in vitro expansion and cytokine profile of thymic and splenic Treg cells.
    Pap R; Ugor E; Litvai T; Prenek L; Najbauer J; Németh P; Berki T
    Immunobiology; 2019 Mar; 224(2):285-295. PubMed ID: 30612787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new approach to the role of IL-7 and TGF-ß in the in vitro generation of thymus-derived CD4+CD25+Foxp3+ regulatory T cells.
    Bieńkowska A; Kiernozek E; Kozlowska E; Bugajski Ł; Drela N
    Cytokine; 2018 Feb; 102():107-116. PubMed ID: 28826649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement for POH1 in differentiation and maintenance of regulatory T cells.
    Liu Y; Zhang L; Wang B; Yang Z; Xu G; Ma A; Tang M; Jing T; Wu L; Xu X; Liu Y
    Cell Death Differ; 2019 Mar; 26(4):751-762. PubMed ID: 30038387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A peptide derived from the Wiskott-Aldrich syndrome (WAS) protein-interacting protein (WIP) restores WAS protein level and actin cytoskeleton reorganization in lymphocytes from patients with WAS mutations that disrupt WIP binding.
    Massaad MJ; Ramesh N; Le Bras S; Giliani S; Notarangelo LD; Al-Herz W; Notarangelo LD; Geha RS
    J Allergy Clin Immunol; 2011 Apr; 127(4):998-1005.e1-2. PubMed ID: 21376381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of highly polymorphic T cell populations in siblings with the Wiskott-Aldrich Syndrome.
    Lutskiy MI; Park JY; Remold SK; Remold-O'Donnell E
    PLoS One; 2008; 3(10):e3444. PubMed ID: 18941616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.